Late Start On Ebola Therapies Means Outbreak Outpacing Drug, Vaccine Development
ScienceInsider: Ebola vaccine: Little and late
“…Administration officials have begun working with industry to speed manufacturing of experimental drugs and vaccines [for Ebola]. ‘We’re trying to do everything we can to scale up product,’ says Nicole Lurie, assistant secretary for preparedness and response at the U.S. Department of Health and Human Services (HHS). But the logistical obstacles are huge, and makers are getting a late start…” (Cohen, 9/16).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.